By a GenomeWeb staff reporter

This article has been updated from a previous version to include comments from company officials.

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its second-quarter revenues increased 19 percent year over year, and the firm posted its first-ever quarterly profit.

However, citing "market and economic conditions," the firm lowered its revenue and earnings guidance for the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.